Journal Articles
2020

Does increasing packing density using larger caliber coils improve
angiographic results of embolization of intracranial aneurysms at
1 year: A randomized trial
J. Raymond
J. Ghostine
B. A. Van Adel
J. J. Shankar
D. Iancu

See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Neurosurgery Commons

Recommended Citation
Raymond J, Ghostine J, Van Adel BA, Shankar JJ, Iancu D, Mitha AP, Kvamme P, Turner RD, Woo HH,
Darsaut TE, . Does increasing packing density using larger caliber coils improve angiographic results of
embolization of intracranial aneurysms at 1 year: A randomized trial. . 2020 Jan 01; 41(1):Article 7498 [
p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/7498. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic
Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara
Zucker School of Medicine Academic Works. For more information, please contact academicworks@hofstra.edu.

Authors
J. Raymond, J. Ghostine, B. A. Van Adel, J. J. Shankar, D. Iancu, A. P. Mitha, P. Kvamme, R. D. Turner, H. H.
Woo, T. E. Darsaut, and +13 additional authors

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/7498

LEVEL 1 EVIDENCE-BASED MEDICINE

EXPEDITED PUBLICATION

Does Increasing Packing Density Using Larger Caliber Coils
Improve Angiographic Results of Embolization of Intracranial
Aneurysms at 1 Year: A Randomized Trial
J. Raymond, J. Ghostine, B.A. van Adel, J.J.S. Shankar, D. Iancu, A.P. Mitha, P. Kvamme, R.D. Turner, A. Turk,
V. Mendes-Pereira, J.S. Carpenter, S. Boo, A. Evans, H.H. Woo, D. Fiorella, A. Alaraj, D. Roy, A. Weill,
P. Lavoie, M. Chagnon, T.N. Nguyen, J.L. Rempel, and T.E. Darsaut

ABSTRACT
BACKGROUND AND PURPOSE: The impact of increased aneurysm packing density on angiographic outcomes has not been studied
in a randomized trial. We sought to determine the potential for larger caliber coils to achieve higher packing densities and to
improve the angiographic results of embolization of intracranial aneurysms at 1 year.
MATERIALS AND METHODS: Does Embolization with Larger Coils Lead to Better Treatment of Aneurysms (DELTA) was an investigator-initiated multicenter prospective, parallel, randomized, controlled clinical trial. Patients had 4- to 12-mm unruptured aneurysms. Treatment allocation to either 15- (experimental) or 10-caliber coils (control group) was randomized 1:1 using a Web-based platform. The primary efﬁcacy
outcome was a major recurrence or a residual aneurysm at follow-up angiography at 12 6 2 months adjudicated by an independent core lab
blinded to the treatment allocation. Secondary outcomes included indices of treatment success and standard safety outcomes.
Recruitment of 564 patients was judged necessary to show a decrease in poor outcomes from 33% to 20% with 15-caliber coils.
RESULTS: Funding was interrupted and the trial was stopped after 210 patients were recruited between November 2013 and June
2017. On an intent-to-treat analysis, the primary outcome was reached in 37 patients allocated to 15-caliber coils and 36 patients
allocated to 10-caliber coils (OR = 0.931; 95% CI, 0.528–1.644; P = .885). Safety and other clinical outcomes were similar. The 15-caliber
coil group had a higher mean packing density (37.0% versus 26.9%, P = .0001). Packing density had no effect on the primary outcome
when adjusted for initial angiographic results (OR = 1.001; 95% CI, 0.981–1.022; P = .879).
CONCLUSIONS: Coiling of aneurysms randomized to 15-caliber coils achieved higher packing densities compared with 10-caliber coils, but
this had no impact on the angiographic outcomes at 1 year, which were primarily driven by aneurysm size and initial angiographic results.

E

ndovascular embolization of intracranial aneurysms with platinum coils has been shown to be effective for preventing
rebleeding in aneurysmal SAH and is a widely offered treatment
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for the primary prevention of SAH from unruptured aneurysms.1,2 However, aneurysm recurrence following initial treatment is not infrequent, leading to long-term angiographic
surveillance and retreatment when aneurysms recur.3 A multicenter registry has reported up to 15% retreatment rates at 2 years
after coiling of ruptured aneurysms, but a yearly rerupture rate of
only 0.2% after the first year.4 Recurrence has been linked to several factors, including rupture status, aneurysm size, neck width,
initial angiographic results of treatment, and packing density.5,6
Large-caliber platinum coiling systems (15-caliber coils) have
been introduced for use in relatively small aneurysms. The aim
was to more completely fill the aneurysm sac with embolic material.7 We sought to determine the potential for those larger caliber
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coils to achieve higher packing densities in 4- to 12-mm aneurysms and ultimately to decrease the rate of poor angiographic
outcomes at 1 year. The Does Embolization with Larger Coils
Lead to Better Treatment of Aneurysms (DELTA) trial was initiated to examine the safety and efficacy of endovascular coil
embolization with 15-caliber coils (DELTAMAXX Microcoil;
DePuy Synthes, Codman for Neuro, Raynham, Massachusetts)
compared with embolization with 10-caliber coils in patients
with small-to-medium-sized aneurysms. The prespecified pilot
phase reporting the capacity for 15-caliber coils to increase packing density compared with 10-caliber coils has been previously
published.8 The hypothesis of the pivotal study was a decrease in
the rate of residual aneurysm and recurrence at 1 year from 33%
with 10-caliber to 20% with 15-caliber coils, necessitating the
recruitment of 564 patients (a, 5%; b error, 10%). Recruitment
was stopped on December 5, 2108, because financial support was
interrupted despite the recommendation of the trial Data Safety
and Monitoring Committee (DSMC) to pursue the trial. We
report here the final results of the DELTA trial.

MATERIALS AND METHODS
Trial Design
DELTA was an investigator-initiated multicenter prospective,
parallel, randomized, controlled, single-blind clinical trial. The
study is registered and summarized on https://clinicaltrials.gov/,
NCT01943591, and the full protocol can be found at http://bit.ly/
2DZcTot. There were no changes to the protocol during the conduct of the trial.

Eligibility Criteria
The trial had wide inclusion criteria: adult patients with at least 2
years of life expectancy, having a ruptured (World Federation of
Neurosurgical Societies grades I–III SAH) or unruptured 4- to
12-mm intracranial aneurysm, considered for endovascular coil
embolization and amenable for treatment with either 15- or 10caliber coils. There were few exclusion criteria: patients with
planned treatment of an associated cerebral arteriovenous malformation and those for whom parent vessel occlusion was the
primary intent of the procedure.

Participating Centers
The trial was to be conducted in approximately 20 neurovascular
centers with experience in endovascular treatment of aneurysms
(at least 100 patients previously treated).

Interventions
Patients allocated to the 15-caliber coiling group were preferably
to receive as many 15-caliber platinum coils as safely achievable,
but the procedure could be completed with 10-caliber filling or
finishing coils, to optimize complete occlusion. Patients allocated
to the 10-caliber coiling group were to receive only platinum coils
of the latter size. Operators had the technical freedom to use any
adjunctive technique, such as balloon-assisted or stent-assisted
coil embolization. The study did not require any additional testing or procedure other than routine practice at the participating
center.
30
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To explore some explanatory analyses in case of nonconclusive intent-to-treat analyses, we prespecified a coiling protocol
deviation to occur in the 15-caliber coil group when ,30% of coil
length was 15-caliber coils; in the 10-caliber coil group, any use of
15-caliber coils was considered a coiling protocol deviation.
Coiling protocol deviations were included in their allocated coil
group in intent-to-treat analyses but were removed from their
allocated coil group (ie, not considered as crossovers) in the perprotocol analyses.

Randomization
Randomized (1:1) allocation of treatment groups was concealed
using a Web-based platform, and the rupture status and previous
treatment of the aneurysm were used as minimization criteria.

Outcomes
The primary efficacy outcome measure was a composite end
point consisting mostly of the occurrence of a major recurrence
or a residual aneurysm at the time of follow-up angiography at
12 6 2 months, as adjudicated by an independent core lab
blinded to the treatment allocation. The degree of aneurysm
occlusion was adjudicated according to the Montreal scale (complete occlusion, residual neck, or residual aneurysm).5 In the absence of follow-up imaging, other components of the composite
primary end point were adjudicated by an independent committee according to the following prespecified criteria of treatment
failures (expected to be infrequent): initial treatment failure,
when no coils were deployed; hemorrhage during the follow-up
period; retreatment of the same lesion by endovascular or surgical
means during the follow-up period; occurrence or progression of
mass effect in relation to the treated aneurysm; or treatmentrelated morbidity and mortality precluding follow-up angiography.
Secondary outcomes included indices of immediate treatment
success, individual components of the composite primary outcome, and standard safety outcomes: initial technical success of
the coiling strategy; use of adjunctive devices; number and total
length of coils implanted for each type; packing density; time of
fluoroscopic exposure (the addition of the time, in minutes, for
both detectors of the biplane angiography unit); immediate
angiographic results according to the Montreal scale; major recurrence on follow-up angiography; procedure-related serious
adverse events; any adverse event; length of hospital stay; discharge
destination; mRS at discharge and at 1-year follow-up; and morbidity and mortality that precluded angiographic follow-up.

Packing Density
Packing density or volume embolization ratio is the volume of
inserted coils divided by the aneurysm volume. Coil volume was
calculated using the following formula: V = p (c/2)2L, where c is
coil caliber and L is coil length for coils entered in the procedural
case report forms. Aneurysm volumes were determined using a
simple mathematic model: V = 4/3 p ab(a þ b)/2, where a and b
are half of the long and short axes of the aneurysm, as entered on
the procedural case report forms.

Analyses
Descriptive statistics were obtained on demographic variables
and aneurysm characteristics to compare the 2 groups at baseline.

Means, SDs, and range are presented for quantitative variables,
and frequency tables, for categoric variables. Comparability of the
groups was assessed through an independent Student t test
(quantitative data) or exact x 2 tests (categoric data). The primary
outcome, recurrence rates (for both intent-to-treat and per-protocol groups), was compared between groups through x 2 tests
and odds ratios with 95% confidence intervals. Logistic regression
was used to examine an association between packing density and
primary outcome. Secondary outcomes and safety data were
compared between groups through independent Student t tests
(quantitative variables) or exact x 2 statistics (categoric data).
Finally, logistic regression was used to find variables capable of
predicting recurrences. The variables were selected using the stepwise forward approach based on likelihood using a , .05 for inclusion. Possible predictors included the type of aneurysm, size of the
aneurysm, size of the neck, immediate angiographic results, and
packing density. Analyses were performed using SPSS, Version 25
(IBM, Armonk, New York) and a significance level of 5%.

Trial Conduct
The trial was sponsored by the Center Hospitalier de l’Université
de Montréal and funded by Johnson & Johnson Medical
Products, a division of Johnson & Johnson and DePuy Synthes.
The sponsor and funder had no role in study design, data collection, analysis, or reporting and had no direct or indirect access to
the data or source documents. The Steering Committee bears the
sole responsibility for all aspects of the trial.

RESULTS
Between November 2013 and June 2017, two hundred ten
patients were recruited in 12 North American centers: One hundred four patients were allocated to the 15-caliber group versus
106 to the 10-caliber group. The trial profile is shown in Fig 1.
The baseline patient and aneurysm characteristics of the 2 groups
were similar (Table 1).
The primary outcome could be adjudicated in 201 patients
(96%). Results are summarized in Table 2. In the intent-to-treat
analysis, the primary outcome was reached in 37 patients allocated to 15-caliber coils compared with 36 patients allocated to
10-caliber coils (OR = 0.931; 95% CI, 0.528–1.644; P = .885).
Including the “not attributed” cases in the “primary outcome
met” category or repeating analyses using per-protocol definitions did not change the results.
There was no significant difference in the use of adjunctive
devices between the 2 groups. Stents were used in 19 of 101 or
19% of patients in the 10-caliber group compared with 23 of 102
or 23% of patients in the 15-caliber group (P = .458). For patients
treated with stent-assisted coiling, the primary outcome was met
in 4 of 19 patients in the 10-caliber group compared with 7 of 23
patients in the 15-caliber group (P = .726).
Safety and other clinical outcomes were similar for the 2
groups (On-line Table 1). Fluoroscopy times were similar (71 6
45 versus 64 6 38 minutes, P = .232). Serious adverse events
(Table 3) occurred in 25 patients, 7 in the 15-caliber group and
18 in the 10-caliber group, including 9 deaths, 2 in the 15-caliber
and 7 in the 10-caliber group (P = .053). Other secondary outcomes were similar, except for the mean number of coils, which

FIG 1. Trial proﬁle. SAEs indicates severe adverse events.
Table 1: Patient demographics and aneurysm characteristicsa
10-Caliber 15-Caliber
Coils
Coils
(n = 106)
(n = 104)
Female sex
81 (76.4%)
82 (78.8%)
Age (mean) (SD) (yr)
57 (11)
58 (10)
mRS at baseline .2
2 (1.9%)
3 (2.9%)
Multiple aneurysms (No.) (%)
29 (27.4%)
29 (27.9%)
Ruptured aneurysms
(No.) (%) of treatment group
35 (33.0%)
36 (34.6%)
(No.) (%) recurrence
0
1 (1.0%)
Unruptured aneurysms
(No.) (%) of treatment group
71 (67.0%) 68 (65.4%)
(No.) (%) recurrence
4 (3.8%)
3 (2.9%)
(No.) (%) symptomatic
7 (6.6%)
5 (4.8%)
Aneurysm size (maximal dimension)
Mean (SD) (mm)
7.7 (2.6)
7.8 (2.3)
Aneurysm neck
Mean (SD) (mm)
3.2 (1.1)
3.3 (1.3)
Neck $4.0 (mm)
39 (36.8%)
31 (29.8%)
Aneurysm location, anterior (No.) (%)
81 (76.4%) 88 (84.6%)
Internal carotid
36 (34.0%)
42 (40.4%)
Anterior cerebral
32 (30.2%)
31 (29.8%)
Middle cerebral
13 (12.3%)
15 (14.4%)
Aneurysm location, posterior (No.) (%)
25 (23.6%)
16 (15.4%)
Basilar
18 (17.0%)
12 (11.5%)
Other posterior
7 (6.6%)
4 (3.8%)
a

No signiﬁcant difference was found between groups on any of the parameters.

Table 2: Primary outcomea

Primary outcome met
Major recurrence
Retreatment
Initial treatment failure
SAH
Related mortality
Related morbidity
Good outcome
Not attributed
Lost to follow-up
Unrelated mortality

10-Caliber Coils
(n = 106)
36 (34.0%)
20 (18.9%)
4 (3.8%)
6 (5.7%)
1 (0.9%)
5 (4.7%)
0
64 (60.4%)
6 (5.7%)
4 (3.8%)
2 (1.9%)

15-Caliber Coils
(n = 104)
37 (35.6%)
26 (25.0%)
4 (3.8%)
4 (3.8%)
0
2 (1.9%)
1 (1.0%)
64 (61.5%)
3 (2.9%)
3 (2.9%)
0

a
No signiﬁcant difference between groups was found in the primary outcome.
Data are (No.) (%).
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was significantly smaller for 15-caliber coils (On-line Table 2).
The 15-caliber coil group had a higher mean packing density
(37.0% versus 26.9%, P = .001, 2-tailed t test; excluding cases in
which coils could not be deployed). Exploratory per-protocol
analyses excluded all coiling protocol violations (n = 21; 4 in the
10-caliber group, 17 in the 15-caliber group), initial treatment
Table 3: Serious adverse events
10-Caliber Coils
(n = 106)
Mortality, total (No.) (%)
7 (6.6%)
Aneurysm rupture during
2 (1.9%)
procedure
Stroke, periprocedural
2 (1.9%)
Stroke, related to SAH at
1 (0.9%)
presentation
Related to SAH during
0
follow-up
Unrelated to aneurysm or
2 (1.9%)
its treatment
Morbidity, total (No.) (%)
11 (10.4%)
Aneurysm rupture during
4 (3.8%)
procedure
Stroke
6 (5.7%)
SAH during follow-up
1 (0.9%)

15-Caliber Coils
(n = 104)
2 (1.9%)
1 (1.0%)

failures (n = 11), and patients with no 12-month follow-up
(n = 17). In those exploratory analyses, the most important predictor of long-term results was the immediate angiographic
result. Other predictors were aneurysm size and rupture status of
the aneurysm. Packing density was a significant predictor in univariate analysis, but packing density had no effect on the primary
outcome when adjusted for initial angiographic results (OR =
1.001; 95% CI, 0.981–1.022; P = .897).

DISCUSSION

Packing density has been conceived as an estimate of the extent
to which an aneurysm is filled with embolic coiling material.9-11
It has been thought to play a role in objectively estimating the
0
success of the initial endovascular treatment, at least compared
0
with other, more subjective end points such as angiographic
results.12 Inferior packing density has been associated with an
1 (1.0%)
increased risk of angiographic recurrences in some observational
0
follow-up angiographic studies,13-15 but randomized evidence
had not been available before the DELTA study. Even though
5 (4.8%)
packing density can be calculated with relative ease, its value in
3 (2.9%)
predicting inferior follow-up angiographic results remains con2 (1.9%)
troversial.16,17 Packing density, though objective because based
0
on mathematical calculations, can be predictive of long-term
angiographic outcome only after
treatment. Packing density is not independent of other risk factors for recurrences that can be determined before
treatment, such as aneurysm size,
neck width, and the ruptured or
unruptured nature of the aneurysm.5,6,14,15,18 In addition, if there is
an association between packing density
and immediate angiographic results,
there are intuitive and empiric reasons
to believe that immediate angiographic
results are causally more pertinent to
treatment success, in the long term,
than packing density (Fig 2).
It would not be possible to undertreat or overtreat aneurysms in a
deliberate, prospective, and randomized fashion, using the same platinum
coil technology, keeping all other variFIG 2. Effect of packing density and immediate angiographic results. From left to right, decreasing
ables similar, to experimentally study
packing density has an impact, but it depends on inferior immediate angiographic results. From
the effects of packing density on longupper to lower rows, increasing packing density, given the same initial angiographic results, has no
impact on long-term angiographic results.
term results. However, comparing 2
groups of patients with relatively
small aneurysms randomly allocated
to the exclusive use of 10-caliber
platinum coils, considered the control group, or to as many 15-caliber
coils as possible, considered the experimental group, keeping all other
treatment variables the same, allowed
us to examine the potential effects of
FIG 3. Effect of packing density and immediate angiographic results. Packing density is better
packing density isolated from all other
thought of as an index compounding many causal factors, such as aneurysm and neck sizes and
immediate angiographic results, rather than a true causal factor in long-term angiographic results.
causal factors.
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Packing density is not an end in itself, but it was used as an
end point of the pilot phase because it was thought that if the use
of larger caliber coils (the only difference between the 2 platinum
coil treatment groups) could not impact packing density, it would
be unlikely to change the treatment substantially enough to
impact long-term angiographic results.
The use of larger caliber coils did succeed in increasing packing density,8 but this had no impact on the primary outcome of
the trial, the 1-year angiographic results. We must, of course,
remember that the trial was interrupted prematurely. Nevertheless,
our exploratory per-protocol data provide experimental evidence
supporting an explanation regarding the potentially misleading idea
that increasing packing density by itself improves the long-term
results of coil embolization (Fig 2). While univariate analyses reveal
a significant association between packing density and long-term
results, there are also strong associations between aneurysm and
neck sizes (predictive factors before treatment) and packing density.
In addition, when adjusted for immediate angiographic results,
packing density had no influence on results. In other words, packing
density is more correctly an indicator rather than a true causal factor
in recurrences (Fig 3).
Some authors have argued that packing density is not such an
important factor when aneurysms are stented.19,20 The subgroup of
stented aneurysms in DELTA was too small to draw any conclusions.
Our study has several limitations. The trial was interrupted
before the target number of patients had been recruited. The
resulting study cannot provide definitive conclusions. The follow-up period was relatively short. The method used to calculate
aneurysm volumes is not as accurate as more exact experimental
methods,6,21 but it is simple, immediately available, and in common clinical usage. Similar methods have been used in most published trials.22 This method likely results in an overestimation of
aneurysm volumes and an underestimation of packing densities,
but it is unlikely to introduce bias in the comparison because of
random allocation and because measurement errors are expected
to be the same for both groups.

CONCLUSIONS
Coiling of aneurysms randomized to 15-caliber coils achieved
higher packing densities compared with 10-caliber coils, but this
finding had no impact on the angiographic outcomes at 1 year,
which were primarily driven by aneurysm size and initial angiographic results.
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